U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback